---
schema_version: "secwatch.filing_event.v1"
accession: "0001193125-22-242001"
form_type: "8-K"
ticker: "NERV"
cik: "0001598646"
company_name: "Minerva Neurosciences, Inc."
filed_at: "2022-09-09T23:59:59+00:00"
generated_at: "2026-06-23T11:58:03.716187+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.6
calibrated_materiality_score: 0.6
confidence: "high"
source: SEC EDGAR
---

# Minerva Neurosciences transfers stock listing to Nasdaq Capital Market to avoid delisting

## Summary
- Transfer from Nasdaq Global Market to Nasdaq Capital Market effective Sept 12, 2022; ticker NERV unchanged.
- Company was not in compliance with minimum $10M net equity requirement previously disclosed on March 8, 2022.
- Nasdaq approved transfer under Listing Rule 5810(c)(3)(A); company meets all Capital Market continued listing criteria.
- No impact on trading; press release issued Sept 9, 2022.

## SEC filing metadata
- accession: 0001193125-22-242001
- form_type: 8-K
- ticker: NERV
- cik: 0001598646
- company_name: Minerva Neurosciences, Inc.
- filed_at: 2022-09-09T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.6
- calibrated_materiality_score: 0.6
- confidence: high
- sec_items: 3.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1598646/000119312522242001/0001193125-22-242001-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1598646/000119312522242001/d382794d8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001193125-22-242001
- JSON: https://secwatch.observer/filing/0001193125-22-242001.json
- Plain text: https://secwatch.observer/filing/0001193125-22-242001.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.